http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103018446-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a21d74f8dfc6313f43b139076f4f45c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-558 |
| filingDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a575889cef2cd31d9644b562e7797f74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_683ccbbd7eb60482dac5e22d76fb962d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e31923c536f0345ef2b5d06f7224e89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c22a8e31e628f723f040f5066d6d4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f16eb45c4497e020133b1cd6b7e8d607 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_708481c121dc5165c4c6164ca37298d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_455fe3673417902eeff1fe3c2fb29892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5490ed532cde15e00f5e75e77f972f91 |
| publicationDate | 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103018446-B |
| titleOfInvention | Method for detecting hepatitis A virus antibodies, kit for detection through method and preparation method for kit |
| abstract | The invention relates to the technical field of biology, in particular to a method for detecting hepatitis A virus antibodies, a kit for detection through the method and a preparation method for the kit. Antihuman IgM (immunoglobulin m) and antihuman IgG (immunoglobulin g) are fixed on a membrane respectively; blood serum to be detected are added; after the hepatitis A antibodies in the blood serum to be detected are combined with the antihuman IgM and the antihuman IgG fixed on the membrane, enzyme-labeled hepatitis A antigen solution is added; and finally, color development solution is added for color development so as to display the result. The invention has the advantages as follows: false positive interference in the result caused by rheumatoid disease factors in a sample can be eliminated, the process that enzyme labels hepatitis A antigen is enabled to be quicker and more efficient, and meanwhile, the antibody cost of the kit is lowered. |
| priorityDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.